Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

Clinical trial NCT01055496 · COMPLETED

Trial details

NCT number: NCT01055496
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2010-03-01
Primary completion: 2013-07-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.